• Something wrong with this record ?

Účast EDRF-NO v regulacích kostního průtoku krve u potkanů: inhibice s L-NAME [The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME]

J. Kapitola, J. Andrle, T. Haas, J. Kubícková,

. 1996 ; 97 (4) : 455-461.

Language Czech Country Czech Republic

Document type English Abstract, Journal Article, Research Support, Non-U.S. Gov't

Digital library NLK
Source

E-resources Online
Links

PubMed 9424710

EDRF-NO probably participates-besides the prostaglandins [3, 4]-in local circulatory changes in the bones of female rats with modified level of sex hormones; we could demonstrate it indirectly using methylene blue as a blocking agent [5]. In this paper, we present corresponding results of two experiments with NG-nitro-arginine methyl ester (L-NAME) as a substance blocking the production of endothelium derived relaxing factor, i.e. nitric oxide (EDRF-NO). Circulatory values were estimated by means of 85Sr-microspheres. In experiment A we ascertained whether the duration of L-NAME administration (0.025% in the food) influenced the effect. It could be demonstrated that the effect of one week's, two weeks', or four weeks' administration of L-NAME was the same: 85Sr-microsphere uptake and blood flow throught the tibia of female rats, increased after oophorectomy (OOX, performed four weeks prior to the experiment), was significantly suppressed to the level in sham-operated animals. In the experiment B, L-NAME was administered in the food in concentration of 0.05% for two weeks prior to the experiment. 85Sr-microsphere uptake was decreased significantly after L-NAME in the tibia of sham-operated females, in the tibia and distal femur of OOX animals; no significant changes were found in the diaphysis of femur and in calvaria. Blood flow values were significantly decreased in all bone samples of OOX females and in tibia of sham-operated rats (besides the local reaction also due to the decrease in the cardiac output). In both experiments the cardiac output was decreased and blood pressure elevated after L-NAME. It can be concluded, from the results of both experiments, that the blockade of EDRF-NO production by L-NAME decreases local circulatory values in the bones of female rats-particularly OOX-in a similar way as methylene blue; however, in contrast to methylene blue, L-NAME induces marked increase in the blood pressure and partially decrease in the cardiac output. Thus, as in the case of methylene blue, the effect of L-NAME on the circulation of blood in the rat bones supports the hypothesis of the participation of EDRF-NO in bone blood flow regulations.

The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME

000      
00000naa a2200000 a 4500
001      
bmc18027804
003      
CZ-PrNML
005      
20180809102134.0
007      
ta
008      
180809s1996 xr f 000 0|cze||
009      
AR
035    __
$a (PubMed)9424710
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a cze
044    __
$a xr
100    1_
$a Kapitola, J $u Laborator pro endokrinologii a metabolismus, lékarské fakulty Univerzity Karlovy, Praha, Czech Republic.
245    10
$a Účast EDRF-NO v regulacích kostního průtoku krve u potkanů: inhibice s L-NAME / $c J. Kapitola, J. Andrle, T. Haas, J. Kubícková,
246    31
$a The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME
520    9_
$a EDRF-NO probably participates-besides the prostaglandins [3, 4]-in local circulatory changes in the bones of female rats with modified level of sex hormones; we could demonstrate it indirectly using methylene blue as a blocking agent [5]. In this paper, we present corresponding results of two experiments with NG-nitro-arginine methyl ester (L-NAME) as a substance blocking the production of endothelium derived relaxing factor, i.e. nitric oxide (EDRF-NO). Circulatory values were estimated by means of 85Sr-microspheres. In experiment A we ascertained whether the duration of L-NAME administration (0.025% in the food) influenced the effect. It could be demonstrated that the effect of one week's, two weeks', or four weeks' administration of L-NAME was the same: 85Sr-microsphere uptake and blood flow throught the tibia of female rats, increased after oophorectomy (OOX, performed four weeks prior to the experiment), was significantly suppressed to the level in sham-operated animals. In the experiment B, L-NAME was administered in the food in concentration of 0.05% for two weeks prior to the experiment. 85Sr-microsphere uptake was decreased significantly after L-NAME in the tibia of sham-operated females, in the tibia and distal femur of OOX animals; no significant changes were found in the diaphysis of femur and in calvaria. Blood flow values were significantly decreased in all bone samples of OOX females and in tibia of sham-operated rats (besides the local reaction also due to the decrease in the cardiac output). In both experiments the cardiac output was decreased and blood pressure elevated after L-NAME. It can be concluded, from the results of both experiments, that the blockade of EDRF-NO production by L-NAME decreases local circulatory values in the bones of female rats-particularly OOX-in a similar way as methylene blue; however, in contrast to methylene blue, L-NAME induces marked increase in the blood pressure and partially decrease in the cardiac output. Thus, as in the case of methylene blue, the effect of L-NAME on the circulation of blood in the rat bones supports the hypothesis of the participation of EDRF-NO in bone blood flow regulations.
650    _2
$a zvířata $7 D000818
650    _2
$a rychlost toku krve $x účinky léků $7 D001783
650    _2
$a kosti a kostní tkáň $x krevní zásobení $7 D001842
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a femur $x krevní zásobení $7 D005269
650    _2
$a hemodynamika $x účinky léků $7 D006439
650    _2
$a methylenová modř $x farmakologie $7 D008751
650    _2
$a NG-nitroargininmethylester $x farmakologie $7 D019331
650    _2
$a oxid dusnatý $x antagonisté a inhibitory $x biosyntéza $x fyziologie $7 D009569
650    _2
$a ovarektomie $7 D010052
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a regionální krevní průtok $x účinky léků $7 D012039
650    _2
$a radioizotopy stroncia $7 D013326
650    _2
$a tibie $x krevní zásobení $7 D013977
655    _2
$a anglický abstrakt $7 D004740
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Andrle, J
700    1_
$a Haas, T
700    1_
$a Kubícková, J
773    0_
$w MED00011096 $t Sborník lékařský $x 0036-5327 $g Roč. 97, č. 4 (1996), s. 455-461
856    41
$u https://pubmed.ncbi.nlm.nih.gov/9424710 $y Pubmed
910    __
$a ABA008 $b A 7 $c sign $y 4 $z 0
990    __
$a 20180809 $b ABA008
991    __
$a 20180809102458 $b ABA008
999    __
$a ok $b bmc $g 1324633 $s 1024755
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 1996 $b 97 $c 4 $d 455-461 $i 0036-5327 $m Sborník lékařský (1910) $n Sb. lék. (1910) $x MED00011096
LZP    __
$a Pubmed-20180809

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...